Investor mix
6 investors on record; lead investors include Israel Biotech Fund, JVC Investment Partners, JK&B Capital, Generali.
| Investor type | Count | Share |
|---|---|---|
| Venture capital | 5 | 83% |
| Other / undisclosed | 1 | 17% |
Pharma Two B is a late-stage pharmaceutical company developing innovative combination products of previously approved drugs to treat early Parkinson's disease and liver diseases.
6 investors on record; lead investors include Israel Biotech Fund, JVC Investment Partners, JK&B Capital, Generali.
| Investor type | Count | Share |
|---|---|---|
| Venture capital | 5 | 83% |
| Other / undisclosed | 1 | 17% |